Scientist / Senior Scientist, Translational Exploratory Clinical Immunology

Jounce Therapeutics Cambridge , MA 02138

Posted 2 months ago

Role / Responsibilities

Jounce Therapeutics is seeking an experienced translational immunologist to join the TranslationalExploratory and Clinical Immunology team and contribute to the development of novel cancerimmunotherapies. The successful candidate will be responsible for managing multiple aspects ofbiomarker assays in on-going clinical trials. They will be applying Flow Cytometry and otherimmunoassays to develop and execute on a predicative and pharmacodynamic biomarker strategy. Aspart of a multi-disciplinary team, they will be expected to proactively interact with project teams, externalcollaborators and drive lab-based research to bring best-in-class biomarker strategies to Jounce clinicalprograms.

  • Contribute scientific leadership to Jounce clinical programs, representing function within largerprogram team for vopratelimab development.

  • Gain subject matter expertise for on-going clinical biomarker assays for vopratelimabdevelopment in the SELECT trial and beyond.

  • Work cross-functionally within Research to identify and establish assays and technologies tosupport mechanistic studies and biomarker validation.

  • Manage and guide the development of SOPs for the central lab; manage the scientific review, QCand presentation of external vendor results.

  • Contribute to scientific rationale for combination strategy for Jounce pipeline programs.

  • Train and continuously develop scientists and associates in the Translational ExploratoryImmunology group.


  • Ph.D., M.D. or DVM in Immunology or related field with a minimum of 3 years' experiencerequired, (industrial experience preferred); or MS candidates with a minimum of 10 years'research experience in industry setting and strong scientific background.

  • In-depth knowledge and hands-on experience with Flow Cytometry procedures and demonstratedability to mentor and train junior associates.

  • Hands-on experience with T cell agonists, co-stimulatory molecules and/or ICOS is a plus.

  • Experience with the design, development and analysis of cellular, protein-based, and/ormolecular assays.

  • Good understanding of clinical drug development strategies.

  • Familiarity with coordinating third party outsourced assays, standards, interpretation, andreporting.

  • Experience in immuno-oncology, biologics, molecular biology and cell biology preferred.

  • Demonstrated excellent interpersonal, verbal and written communication skills.

  • Excel in cross-functional, collaborative and fast-paced settings.


Jounce Therapeutics is an equal opportunity employer and does not discriminate in its employmentdecisions on the basis of race, color, national origin, age, physical or mental disability, marital status,religion, creed, sex, or political beliefs. We offer a competitive salary and benefits package. All applicantsshould be legally entitled to work for any employer in the U.S.To apply, please visit

Company Summary

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients through a biomarker-driven approach. Jounce currently has multiple development stage programs ongoing while simultaneously advancing additional early-stage assets from its robust discovery engine based on its Translational Science Platform. Jounce's highest priority program, JTX-8064, is a LILRB2 (ILT4) receptor antagonist shown to reprogram immune-suppressive tumorassociated macrophages to an anti-tumor state in preclinical studies. A Phase 1 clinical trial, named INNATE, for JTX-8064 as a monotherapy and in combination with JTX-4014, Jounce's internal PD-1 inhibitor, or pembrolizumab is currently enrolling patients with advanced solid tumors. Jounce's most advanced product candidate, vopratelimab, is a monoclonal antibody that binds to and activates ICOS, and is currently being studied in the SELECT Phase 2 trial. JTX-4014 is a PD-1 inhibitor intended for combination use in the INNATE and SELECT trials and with Jounce's broader pipeline. Additionally, Jounce exclusively licensed worldwide rights to JTX-1811, a monoclonal antibody targeting CCR8 and designed to selectively deplete T regulatory cells in the tumor microenvironment, to Gilead Sciences, Inc. For more information, please visit

icon no score

See how you match
to the job

Find your dream job anywhere
with the LiveCareer app.
Mobile App Icon
Download the
LiveCareer app and find
your dream job anywhere
App Store Icon Google Play Icon

Boost your job search productivity with our
free Chrome Extension!

lc_apply_tool GET EXTENSION

Similar Jobs

Want to see jobs matched to your resume? Upload One Now! Remove
Scientist I Translational Oncology And Clinical Reporting

Foundation Medicine

Posted 4 days ago

VIEW JOBS 7/31/2021 12:00:00 AM 2021-10-29T00:00 About the Job Job Summary The Scientist I, Translational Oncology and Clinical Reporting makes essential contributions both as an individual contributor and as part of a team in support of Foundation Medicine's medical reporting process by carrying out literature research, scientific analysis, and scientific writing. Regular, systematic review of scientific and medical sources completed by the incumbent in this position inform the creation of a high-quality, personalized diagnostic report for each patient. Close consultation with Medical and Clinical Research teams facilitates report content creation that is concise, informative, and physician-focused. This is a regulated position and additional information may be available from QA on the qualifications for this role pertaining to regulatory guidelines. Key Responsibilities * Identify, interpret, synthesize and succinctly summarize literature and other sources relevant to Foundation Medicine's comprehensive cancer genomic test. * Generate new clinically-focused content and/or guidelines based on review of scientific literature, existing guidelines and other sources. * Collaborate with internal and external scientists and physicians to review, refine, and extend existing medical content. * Contribute to the development and maintenance of Foundation Medicine's clinical oncology knowledgebase. * Develop and contribute to new methods and algorithms to identify and characterize alterations in tumor DNA and RNA derived from clinical cancer specimens. * Provide reporting-related support to external teams, including Foundation Medicine clients. * Lead and contribute to additional projects, both within Biomedical Informatics and between departments, in support of broader Biomedical Informatics and Foundation Medicine goals. * Deliver on tight deadlines. * Other duties as assigned. Qualifications Basic Qualifications * Doctor of Medicine Degree or PhD Degree in Bioinformatics, Computational Biology, or other scientific discipline Preferred Qualifications * 1+ years Postdoctoral work experience or equivalent industry experience * Academic study or work experience with cancer biology, cell biology, biochemistry, molecular biology, disease genetics or clinical oncology * Experience developing algorithms for analysis of biological data, including prior experience with high-throughput sequencing * Experience involving scientific and/or medical communications * Demonstrated ability to rapidly distill clear, complete, and succinct summaries from complex and potentially contradictory primary literature sources * Demonstrated ability to problem solve, within a team and cross-functionally * Deep understanding of genetic and biochemical pathways * Familiarity with current research and topics in cancer genome biology and targeted therapeutics * Strong interpersonal skills, including effective oral and written communication skills * Ability to perform careful, detail-oriented work under deadline pressure * Strong organizational and time-management skills including the ability to manage several projects simultaneously * Understanding of HIPAA and importance of privacy of patient data * Commitment to FMI values: patients, innovation, collaboration, and passion Foundation Medicine Cambridge MA

Scientist / Senior Scientist, Translational Exploratory Clinical Immunology

Jounce Therapeutics